MedTrace Logo

Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic Hepatitis

NCT01341951 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-04-26

No results posted yet for this study

Summary

Granulocyte colony stimulating factor in acute liver failure and alcoholic hepatitis

Conditions

  • Liver Failure, Acute

Interventions

DRUG

Granulocyte colony stimulating factor

300 I.U twice daily for 5 days

Sponsors & Collaborators

  • Post Graduate Institute of Medical Education and Research, Chandigarh

    lead OTHER

Principal Investigators

  • virendra singh · Postgraduate Institute of Medical Education and Research Chandigarh India

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01341951 on ClinicalTrials.gov